Recent data suggest involvement of Acid-Sensing Ion Channel channels in the pathophysiology of migraine making these channels a therapeutic target of migraine disease. The implication of Acid-Sensing Ion Channels is discussed through Acid-Sensing Ion Channel-1 which is the most expressed Acid-Sensing Ion Channel channel subtype in the central nervous system. In a mouse model, cortical spreading depression is inhibited by different Acid-Sensing Ion Channel blockers including amiloride which is a non-selective blocker of the Acid-Sensing Ion Channel-1 channel. From a translational perspective, an efficacy of amiloride on a series of migraine patients suffering from severe aura in open conditions. The APAM study is a proof-of-concept study that aims to evaluate the effect of amiloride in the prophylaxis of migraine with aura. This is a randomized crossover study versus placebo conducted in 3 French headache centers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
40
Treatment by Amiloride vs placebo in crossover
Treatment by Amiloride vs placebo in crossover
Hôpital Pierre Wertheimer
Bron, France
NOT_YET_RECRUITINGCHU Gabriel Montpied
Clermont-Ferrand, France
NOT_YET_RECRUITINGAP-HM
Marly, France
RECRUITINGCHU de Montpellier
Montpellier, France
RECRUITINGCHU de NICE
Nice, France
RECRUITINGNumber of attacks with aura, with or without headache.
Time frame: 12 weeks
Number of days with migraine headache, with or without aura
Time frame: 12 weeks
Functional repercussion
Anxiety and depression score on the Hospital Anxiety and Depression scale scale
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.